{{org_field_logo}}
{{org_field_name}}
Registration Number: {{org_field_registration_no}}
PRN Medication Management Policy
1. Purpose
The purpose of this policy is to ensure that {{org_field_name}} manages PRN (Pro Re Nata) medications efficiently and safely, ensuring that they are administered correctly in accordance with prescriber instructions, service user needs, and regulatory requirements. PRN medication refers to medicines that are given as needed, rather than at scheduled times.
This policy ensures compliance with:
- Regulation and Inspection of Social Care (Wales) Act 2016.
- The Regulated Services (Service Providers and Responsible Individuals) (Wales) Regulations 2017, in particular:
- Regulation 58 (Medicines): safe storage/administration, maintaining supply, ordering/re-ordering, recording, handling, disposal and auditing; and
- Regulation 60 and Schedule 3 (Notifications): reporting notifiable events to CIW without delay (usually within 24 hours).
- Welsh Government Statutory Guidance for care home and domiciliary suppliers (Version 3 – March 2024) (providers and responsible individuals must have regard to this guidance).
- Human Medicines Regulations 2012 (supply/administration of medicines within the UK legal framework).
- Controlled Drugs legislation, including Misuse of Drugs Regulations 2001 and Misuse of Drugs (Safe Custody) Regulations 1973 (where PRN medicines include controlled drugs).
- Mental Capacity Act 2005 (capacity, best interests decision-making and recording when the person cannot consent).
- NICE NG67: Managing medicines for adults receiving social care in the community (best practice for medicines support and records).
2. Scope
This policy applies to:
- All employees, including care workers, managers, and administrative staff involved in medication management.
- Service users receiving PRN medication as part of their care plan.
- Prescribers, pharmacists, and external healthcare professionals who support medication administration.
It covers:
- Definition and purpose of PRN medication.
- PRN assessment, recording, and administration procedures.
- Roles and responsibilities of staff.
- Training and competency requirements.
- Monitoring, review, and regulatory compliance.
This PRN policy is PRN-specific and must be implemented alongside the organisation’s overarching Medication Management and Administration Policy (DCW21), which sets out the full end-to-end medicines system (ordering/re-ordering, receipt, storage standards, reconciliation, audit processes, incident reporting and governance).
3. Definition and Purpose of PRN Medication
PRN medication is prescribed for:
- Pain relief (e.g., paracetamol, ibuprofen).
- Anxiety or agitation (e.g., lorazepam, diazepam).
- Nausea and vomiting (e.g., metoclopramide).
- Constipation (e.g., laxatives).
- Short-term conditions (e.g., antihistamines for allergic reactions).
PRN medications must only be administered when necessary and must follow strict assessment and documentation procedures.
4. PRN Medication Assessment and Care Planning
Before PRN medication is administered, a detailed assessment must be completed to determine:
- The purpose of the medication and expected outcomes.
- When it should be administered (specific symptoms or triggers).
- Minimum and maximum dosage and time intervals.
- Any contraindications, side effects, or drug interactions.
Each service user receiving PRN medication must have a PRN Protocol included in their care plan, specifying:
- The name of the medication.
- The indication for use (e.g., for breakthrough pain or distress).
- The minimum time interval between doses.
- The maximum dosage within 24 hours.
- Alternative non-medication interventions that should be tried first (if applicable).
- Service user preferences regarding PRN medication (if they can communicate their needs).
4.1 Consent and mental capacity
Before PRN medicines support/administration, staff must confirm and record the person’s consent. Where there is reason to doubt capacity to consent to the PRN medicine at the time it is needed, staff must act in accordance with the Mental Capacity Act 2005: presume capacity unless established otherwise, take all practicable steps to support decision-making, and where the person lacks capacity, make and record a best-interests decision in line with the person’s known wishes, feelings, values and the views of those involved in their care.
4.2 Covert administration
Covert administration (disguising medicine in food or drink) must not be used unless it is formally agreed and documented following a best-interests process, with advice from the prescriber/pharmacist, and a clear written plan in the person’s care documentation. Covert administration must be reviewed regularly and stopped as soon as it is no longer necessary.
Where covert medication is provided, it must be administered in line with current best practice guidance.
5. Administration of PRN Medication
5.1 Decision-Making Before Administration
Before administering PRN medication, staff must:
- Assess whether the medication is required by checking symptoms against the care plan.
- Consult the MAR (Medication Administration Record) to ensure the required time interval has passed.
- Gain consent from the service user before administration (unless they lack capacity).
- Where the person lacks capacity at the time the PRN is requested/considered, staff must follow the documented best-interests decision and record the rationale in the daily notes and MAR.
- Check for allergies/sensitivities, current medicines that may interact, and any ‘do not administer’ parameters documented by the prescriber (e.g., sedation score, respiratory rate, maximum daily dose).
- If the PRN medicine is a controlled drug or other high-risk medicine (e.g., opioids, benzodiazepines), follow Section 7.2 (Controlled Drugs) before, during and after administration.
- Seek advice from a healthcare professional if unsure.
5.2 Administering PRN Medication
- PRN medication must be given at the lowest effective dose.
- The route of administration (oral, topical, inhaled) must be followed as per the prescription.
- If the service user refuses the medication, this must be recorded on the MAR chart, and an alternative intervention should be considered.
- Staff must stay with the service user to monitor any immediate side effects.
5.3 Recording PRN Administration
After administering PRN medication, staff must document the following in the MAR chart:
- Date and time of administration.
- Dose given.
- Reason for administration (e.g., pain score, visible discomfort).
- Service user response (e.g., whether the medication was effective).
- Any side effects observed.
6. Roles and Responsibilities
6.1 Responsibilities of the Registered Manager
- Ensure that PRN policies and procedures are implemented and followed.
- Oversee staff training and competency assessments.
- Ensure regular reviews of PRN medication use in line with regulatory requirements.
- Ensure PRN medication stock is correctly stored and disposed of when expired.
6.2 Responsibilities of Care Workers
- Follow PRN medication protocols and only administer PRN medications as per prescription.
- Assess and document when and why PRN medication is needed.
- Monitor for adverse reactions or effectiveness of medication.
- Report any medication concerns to the Registered Manager or healthcare professionals.
6.3 Responsibilities of Healthcare Professionals (GPs, Pharmacists)
- Prescribe PRN medication with clear instructions on dosage and frequency.
- Provide guidance on side effects, contraindications, and interactions.
- Support medication reviews and changes as needed.
6.4 Delegated medication-related tasks
Where a registered healthcare professional delegates a medication-related task (e.g., administration support that goes beyond routine medicines support), the service will follow the All Wales Guidelines for Delegation and ensure:
- the task is explicitly delegated and within the worker’s role;
- the worker has task-specific training and competency assessment;
- supervision/ongoing competence is maintained; and
- documentation clearly distinguishes delegated tasks from routine PRN support.
Delegated tasks must not be undertaken without clear written delegation and confirmation of competence.
7. Storage, controlled drugs, reconciliation and disposal
7.1 Storage in the person’s home (domiciliary setting)
PRN medicines must be stored in the person’s home in line with a risk assessment and the person’s care plan, balancing safety with the person’s independence. Medicines must be kept:
- in original containers with the pharmacy label intact;
- away from heat, moisture and direct sunlight;
- inaccessible to children/others where there is risk of harm.
7.2 Controlled drugs (including PRN controlled medicines)
Where PRN medicines include controlled drugs, additional safeguards apply, including safe custody requirements (locked receptacle/safe as appropriate) and an audit trail of stock movement and administration. Controlled drugs must be managed in line with controlled drugs legislation.
7.3 Reconciliation and stock checks
The service must maintain an effective audit trail for PRN medicines it handles, including:
- recording receipt/supply changes where the service takes possession/handles medicines;
- checking remaining quantities where required by risk assessment (as a minimum for controlled drugs and high-risk PRN medicines);
- escalating discrepancies immediately as a medication incident.
7.4 Disposal
Expired, discontinued or unwanted PRN medicines must be returned to a community pharmacy for safe disposal. Sharps (where applicable) must be disposed of using an appropriate sharps container in line with infection control arrangements.
8. Staff Training and Competency
- All staff must complete mandatory medication training before administering PRN medication.
- Staff must undergo annual refresher training covering:
- Safe handling and storage of medication.
- Correct administration procedures.
- PRN medication protocols and documentation.
- Identifying and reporting side effects.
- Competency assessments are conducted regularly to ensure staff adhere to best practices.
9. Monitoring and Compliance
9.1 Reviewing PRN Medication Use
- PRN medication usage must be reviewed monthly to assess:
- Effectiveness of the medication (e.g., is it working as expected?).
- Frequency of use (e.g., is it being overused or underused?).
- Changes in the service user’s condition requiring medication adjustments.
- Any patterns of increased use or concerns regarding dependency must be reported to the prescribing GP.
9.2 CIW Inspections and Compliance
- Care Inspectorate Wales (CIW) will assess PRN medication practices during inspections.
- Medication audits will be conducted internally to ensure adherence to best practices.
- Any medication errors or near misses must be reported and investigated, with corrective actions taken.
9.3 Medicines audit
The Registered Manager (or delegated competent person) must ensure regular auditing of PRN medicines management, including storage arrangements, MAR/record quality, PRN protocol availability, evidence of review, controlled drug safeguards (where relevant), and learning from errors/near misses. Audits must be recorded, actions allocated, and outcomes reviewed to completion.
9.4 Incident reporting and CIW notifications
All medication errors, near misses, omissions, discrepancies, suspected adverse reactions, or safeguarding concerns must be reported immediately in line with the organisation’s incident procedure, recorded in the MAR/daily notes, investigated, and used for learning.
Where an incident meets CIW notification criteria (Schedule 3), the service must notify CIW without delay (usually within 24 hours) via CIW Online.
10. Related Policies
This policy should be read in conjunction with:
- Medication Management and Administration Policy (DCW21).
- Safeguarding Adults from Abuse and Improper Treatment Policy (DCW13).
- Confidentiality and Data Protection (GDPR) Policy (DCW34).
- Risk Management and Assessment Policy (DCW18).
11. Policy Review
This policy will be reviewed annually or sooner if required by legislative changes, CIW regulations, or operational needs.
Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.